Home Tizona Therapeutics

Tizona Therapeutics

In operation
Equity Financing
Next-Generation Cancer Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Tizona Therapeutics is leveraging novel scientific insights to transform the processes of cancer progression and recurrence. Tizona Therapeutics is developing cancer therapies with the potential to become first-in-class, best-in-class, and core components of combination immunotherapy regimens. Tizona Therapeutics is interested in collaborating with pharmaceutical and biotechnology companies, as well as global academic institutions, to jointly discover and develop treatments that can improve outcomes for cancer patients.
Tizona Therapeutics, Inc.
California,United States of America
15~50 people
January 01, 2014
info@tizonatx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Immunological Techniques
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Biologics Innovative Drugs